FDA NDC Directory · JSON-LD · Markdown

pyrazinamide

NDC 0054-0812 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerHikma Pharmaceuticals USA Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA081319
Dosage form / routeTABLET · ORAL
Active ingredientsPYRAZINAMIDE (500 mg/1)
Marketing started20240830
Package count4

External sources

Source: openFDA. Public-domain (CC0).